22454414Kelly WK, Halabi S, Carducci M, George D, Mahoney JF, Stadler WM, Morris M, Kantoff P, Monk JP, Kaplan E, Vogelzang NJ, Small EJJournal of clinical oncology : official journal of the American Society of Clinical OncologyAdenocarcinoma; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Prostatic NeoplasmsAged; Antibodies, Monoclonal, Humanized; Bevacizumab; Chi-Square Distribution; Disease-Free Survival; Docetaxel; Double-Blind Method; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Odds Ratio; Placebos; Prednisone; Prostate-Specific Antigen; Risk Assessment; Risk Factors; Taxoids; Time Factors; Treatment Outcome; United StatesRandomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401. J Clin Oncol. 2012 May 01; 30(13):1534-40.J Clin Oncol2012-03-26T00:00:002012Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000230Disorders29111600.582288AdenocarcinomaD000368Living Beings1341183530.29479AgedD000971Procedures30624340.47627Antineoplastic Combined Chemotherapy ProtocolsD000726Chemicals & DrugsPhysiology411400.907145Androgen AntagonistsD004311Procedures33818220.70897Double-Blind MethodD008875Concepts & IdeasLiving Beings1473249570.258834Middle AgedD011241Chemicals & Drugs1132550.929584PrednisoneD011471Disorders23517080.438692Prostatic NeoplasmsD012307Concepts & Ideas94153970.464257Risk FactorsAuthorship 480446D006801Living Beings2262862810.130064HumansD013997Concepts & Ideas118351980.519664Time FactorsD014481Geographic Areas102566370.406633United StatesD008297Physiology1931408600.201635MaleD018570Concepts & IdeasProcedures62722530.570997Risk AssessmentD019008Physiology1805890.751147Drug Resistance, NeoplasmD016009Concepts & Ideas2433620.917913Chi-Square DistributionD017430Chemicals & Drugs953460.825516Prostate-Specific AntigenD016896Concepts & Ideas101179490.402421Treatment Outcome0.1087570.1087571authors10.2526has subject areaD018931Chemicals & Drugs631500.911777Antineoplastic Agents, HormonalD010919DevicesProcedures982180.94867PlacebosD043823Chemicals & Drugs561290.941532TaxoidsD061067Chemicals & Drugs2139290.656201Antibodies, Monoclonal, HumanizedD016017Concepts & Ideas2896770.843127Odds RatioD053208Concepts & Ideas3258590.818624Kaplan-Meier EstimateD000068258732810.891448BevacizumabD018572Concepts & Ideas25812030.792724Disease-Free SurvivalMedicineUniversity of ChicagoWalter M.StadlerWalter M. Stadler41.78927490000000-87.601250000000001904Stadler, Walter M.Professortrue1ProfessorProfessor